Doxorubicin
Showing 26 - 50 of 2,767
Breast Cancer Trial in Seoul (Extracorporeal shock waves)
Recruiting
- Breast Cancer
- Extracorporeal shock waves
-
Seoul, Yangcheon Gu, Korea, Republic ofKiwhan Kim
Oct 25, 2022
Basal Cell Carcinoma Trial in Aventura (Placebo-containing MNA, 25 µg doxorubicin-containing MNA, 50 µg doxorubicin-containing
Terminated
- Basal Cell Carcinoma
- Placebo-containing MNA
- +4 more
-
Aventura, FloridaThe Center for Clinical and Cosmetic Research
Aug 16, 2022
Ovarian Cancer Recurrent Trial in Beijing (IN10018, Placebo of IN10018, Pegylated Liposomal Doxorubicin)
Recruiting
- Ovarian Cancer Recurrent
- IN10018
- +2 more
-
Beijing, ChinaCancer Hospital Chinese Academy of Medical Science and Peking Un
Aug 23, 2023
Colon Cancer Liver Metastasis Trial in United States (Lyso-Thermosensitive Liposomal Doxorubicin, 5% Dextrose Solution,
Terminated
- Colon Cancer Liver Metastasis
- Lyso-Thermosensitive Liposomal Doxorubicin
- +2 more
-
Los Angeles, California
- +3 more
Sep 15, 2022
Desmoid Tumor Trial in GuangZhou (Liposome doxorubicin, Saline Solution)
Recruiting
- Desmoid Tumor
- Liposome doxorubicin
- Saline Solution
-
GuangZhou, Guangdong, ChinaSun Yat-sen University cancer center
Sep 29, 2022
Angiosarcoma Metastatic Trial in Guangzhou (Abraxane combined with liposomal doxorubicin)
Recruiting
- Angiosarcoma Metastatic
- Abraxane combined with liposomal doxorubicin
-
Guangzhou, Guangdong, ChinaXing Zhang
Sep 4, 2022
Breast Cancer Trial in New York (Coenzyme Q10, Coenzyme Q10 Placebo)
Completed
- Breast Cancer
- CoQ10
- +3 more
-
New York, New YorkColumbia University Medical Center
Oct 13, 2022
Soft Tissue Sarcoma, Adult, Soft Tissue Sarcoma, Child Trial in Charlotte (Pembrolizumab, Doxorubicin)
Active, not recruiting
- Soft Tissue Sarcoma, Adult
- Soft Tissue Sarcoma, Child
- Pembrolizumab
- Doxorubicin
-
Charlotte, North CarolinaLevine Cancer Institute
Sep 29, 2022
Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma Trial in Toulouse (Doxorubicin, Cyclophosphamide)
Recruiting
- Advanced Soft-tissue Sarcoma
- Metastatic Soft-tissue Sarcoma
- Doxorubicin
- Cyclophosphamide
-
Toulouse, FranceInstitut Claudius Reagaud-IUCT Oncopôle
Oct 6, 2022
Triple Negative Breast Cancer (TNBC) Trial in United States (Combination of liposomal doxorubicin)
Not yet recruiting
- Triple Negative Breast Cancer (TNBC)
- Combination of liposomal doxorubicin
-
Elizabeth, New Jersey
- +7 more
Jul 13, 2023
Relapsed Sarcomas Trial in Cleveland (Disulfiram, Copper Gluconate, Liposomal Doxorubicin (Doxil))
Not yet recruiting
- Relapsed Sarcomas
- Disulfiram
- +2 more
-
Cleveland, OhioCleveland Clinic, Case Comprehensive Cancer Center
Apr 18, 2022
Genetic and Epigenetic Factors on Clinical Response and Toxicity
Recruiting
- Breast Cancer
-
Cairo, EgyptAin Shams University
Feb 8, 2023
Hepatocellular Carcinoma Non-resectable Trial in Belgium, Germany, Italy (BioPearl™)
Not yet recruiting
- Hepatocellular Carcinoma Non-resectable
- BioPearl™
-
Brussels, Belgium
- +5 more
Jun 20, 2023
Solid Tumor, Urethral Cancer Trial in Houston (Bortezomib, Gemcitabine, Doxorubicin)
Active, not recruiting
- Solid Tumor
- Urethral Cancer
- Bortezomib
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 22, 2022
Adrenocortical Carcinoma Trial in Brescia (Etoposide, doxorubicin, cisplatin and Mitotane plus Megestrol Acetate 160 MG,
Recruiting
- Adrenocortical Carcinoma
- Etoposide, doxorubicin, cisplatin and Mitotane plus Megestrol Acetate 160 MG
- Etoposide, doxorubicin, cisplatin and Mitotane plus Placebo
-
Brescia, ItalyAlfredo Berruti
Jun 12, 2023
Advanced Soft-tissue Sarcoma Trial in Nicosia, Amman (Doxorubicin, Cyclophosphamide Oral Product, Prednisolone)
Recruiting
- Advanced Soft-tissue Sarcoma
- Doxorubicin
- +3 more
-
Nicosia, Cyprus
- +1 more
Jul 1, 2022
Cutaneous T Cell Lymphoma Trial in Pittsburgh (Micro needle array-Doxorubicin (MNA-D))
Recruiting
- Cutaneous T Cell Lymphoma
- Micro needle array-Doxorubicin (MNA-D)
-
Pittsburgh, PennsylvaniaUniversity Of Pittsburgh Medical Center
Jun 2, 2022
Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma Trial in
Recruiting
- Fallopian Tube Carcinosarcoma
- +28 more
- Pegylated Liposomal Doxorubicin Hydrochloride
- Peposertib
-
Aurora, Colorado
- +7 more
Sep 2, 2022
Rhabdomyosarcoma, Child Trial (Doxorubicin Hydrochloride Liposome+Irinotecan, Temozolomide+Irinotecan+Vincristine)
Not yet recruiting
- Rhabdomyosarcoma, Child
- Doxorubicin Hydrochloride Liposome+Irinotecan
- Temozolomide+Irinotecan+Vincristine
- (no location specified)
Jul 13, 2022
Advanced Malignant Tumors Trial in Shanghai (doxorubicin HCl liposome injection)
Recruiting
- Advanced Malignant Tumors
- doxorubicin hydrochloride liposome injection
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Apr 28, 2022
Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Phoenix,
Recruiting
- Recurrent Fallopian Tube Carcinoma
- +2 more
- Bevacizumab
- +4 more
-
Phoenix, Arizona
- +2 more
Jun 27, 2022
Sarcoma Trial in Seoul (Durvalumab+doxorubicin cobination)
Active, not recruiting
- Sarcoma
- Durvalumab+doxorubicin cobination
-
Seoul, Korea, Republic ofSeverance Hospital, Yonsei University Health System
May 30, 2022
Ovarian Cancer Trial in Pittsburgh (Pembrolizumab, ALX148, Doxorubicin)
Not yet recruiting
- Ovarian Cancer
- Pembrolizumab
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Jul 19, 2022
Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin
Active, not recruiting
- Advanced Soft Tissue Sarcoma
- +26 more
- Doxorubicin Hydrochloride
- +3 more
-
Portland, OregonOHSU Knight Cancer Institute
Jan 6, 2023